Radioactive Iodine Therapy in Differentiated Thyroid Cancer: 2020 Update
Authors:
- 1 August 2020
- journal article
- review article
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 215 (2) , 285-291
Abstract
OBJECTIVE. The paradigm of theranostics is based on tailoring therapy for the purpose of optimizing outcomes. This principle is being applied to radioactive iodine therapy. Consequently, thyroid ca...Keywords
This publication has 28 references indexed in Scilit:
- Effects of hemodialysis on iodine-131 biokinetics in thyroid carcinoma patients with end-stage chronic renal failureNuclear Medicine Communications, 2016
- 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid CancerThyroid®, 2016
- Radioiodine-remnant ablation in low-risk differentiated thyroid cancer: prosEndocrine, 2015
- Radioiodine remnant ablation in low-risk differentiated thyroid cancer: the “con” point of viewEndocrine, 2015
- Use of Radioiodine after Thyroid Lobectomy in Patients with Differentiated Thyroid Cancer: Does It Change Outcomes?Journal of the American College of Surgeons, 2014
- Low versus high radioiodine activity to ablate the thyroid after thyroidectomy for cancer: a meta-analysis of randomized controlled trialsEndocrine, 2014
- Update on Differentiated Thyroid Cancer StagingEndocrinology and Metabolism Clinics of North America, 2014
- Can radioiodine be administered effectively and safely to a patient with severe chronic kidney disease?Clinical Endocrinology, 2014
- RADIOACTIVE IODINE THERAPYJAMA, 1946
- RADIOACTIVE IODINE IN THE STUDY OF THYROID PHYSIOLOGYJAMA, 1946